Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene

Annals of the New York Academy of Sciences

Volumn 1079, Issue , 2006, Pages 257-267

  Wang, Cong Yi ^a   Podolsky, Robert ^a   She, Jin Xiong ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Antioxidant enzyme; Association; Autoimmunity; Genetic heterogeneity; IkBa; Linkage; NF kB; Odds ratio (OR); Oxidative stress; Pathogenesis; Risk assessment; Sumoylation; Susceptibility

Indexed keywords

SUMO 4 PROTEIN; SUMO PROTEIN;

ASIAN; AUTOIMMUNITY; CAUCASIAN; CONFERENCE PAPER; DIABETOGENESIS; GENE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR BIOLOGY; POPULATION GENETICS; SUMOYLATION; VALIDATION PROCESS;

EID: 33845696665     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1375.039     Document Type: Conference Paper

References (35)

1. LOVISELLI, A., V.M. SOLINAS, E.G. MAMELI, et al. 1999. Genetic markers and insulin-dependent diabetes mellitus (IDDM) in Sardinia. Anthropol. Anz. 57: 25-32.
2. ILONEN, J., O. SIMELL, M. KNIP & H.K. AKERBLOM. 1998. Screening for genetic IDDM risk and prevention trials in infancy. Diabetes Metab. Rev. 14: 188.
3. LOHMANN, T., J. SESSLER, H.J. VERLOHREN, et al. 1997. Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 20: 524-529.
4. KITAGAWA, T., H. FUJITA, S. TSUKASA, et al. 1987. Early phase of juvenile IDDM-environmental and genetic intervention. Acta Paediatr. Jpn. 29: 47-53.
5. GUO, D., M. LI, Y. ZHANG, et al. 2004. A functional variant of SUMO4, a new IkappaBalpha modifier, is associated with type 1 diabetes. Nat. Genet. 36: 837-841.
6. PARK, Y., S. PARK, J. KANG, et al. 2005. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat. Genet. 37: 112-113.
7. NOSO, S., H. IKEGAMI, T. FUJISAWA, et al. 2005. Genetic heterogeneity of SUMO4 M55V variant with susceptibility to type 1 diabetes. Diabetes 54: 3582-3586.
8. DAVIES, J.L., Y. KAWAGUCHI, S.T. BENNETT, et al. 1994. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130-136.
9. LUO, D.F., M.M. BUI, A. MUIR, et al. 1995. Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am. J. Hum. Genet. 57: 911-919.
10. DAVIES, J.L., F. CUCCA, J.V. GOY, et al. 1996. Saturation multipoint linkage mapping of chromosome 6q in type 1 diabetes. Hum. Mol. Genet. 5: 1071-1074.
11. LUO, D.F., R. BUZZETTI, J.I. ROTTER, et al. 1996. Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Hum. Mol. Genet. 5: 693-698.
12. DELEPINE, M., F. POCIOT, C. HABITA, et al. 1997. Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am. J. Hum. Genet. 60: 174-187.
13. JIANG, Z., J. NINOMIYA-TSUJI, Y. QIAN, et al. 2002. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell Biol. 22: 7158-7167.
14. QIAN, Y., M. COMMANE, J. NINOMIYA-TSUJI, et al. 2001. IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFkappa B. J. Biol. Chem. 276: 41661-41667.
15. TAKAESU, G., J. NINOMIYA-TSUJI, S. KISHIDA, et al. 2001. Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol. Cell Biol. 21: 2475-2484.
16. TAKAESU, G., S. KISHIDA, A. HIYAMA, et al. 2000. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5: 649-658.
17. LI, M., D. GUO, C.M. ISALES, et al. 2005. SUMO wrestling with type 1 diabetes. J. Mol. Med. 83: 504-513.
18. OWERBACH, D., L. PINA & K.H. GABBAY. 2004. A 212-kb region on chromosome 6q25 containing the TAB2 gene is associated with susceptibility to type 1 diabetes. Diabetes 53: 1890-1893.
19. SMYTH, D.J., J.M. HOWSON, C.E. LOWE, et al. 2005. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat. Genet. 37: 110-111.
20. QU, H., B. BHARAJ, X.Q. LIU, et al. 2005. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat. Genet. 37: 111-112.
21. WANG, C.Y., P. YANG & J.X. SHE. 2005. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat. Genet. 37: 112-113.
22. SHE, J.X. 1996. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol. Today 17: 323-329.
23. GUO, D., J. HAN, B.L. ADAM, et al. 2005. Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem. Biophys. Res. Commun. 337: 1308-1318.
24. BOHREN, K.M., V. NADKARNI, J.H. SONG, et al. 2004. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J. Biol. Chem. 279: 27233-27238.
25. EIZIRIK, D.L. & T. MANDRUP-POULSEN. 2001. A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44: 2115-2133.
26. EIZIRIK, D.L., B. KUTLU, J. RASSCHAERT, et al. 2003. Use of microarray analysis to unveil transcription factor and gene networks contributing to Beta cell dysfunction and apoptosis. Ann. N. Y. Acad. Sci. 1005: 55-74.
27. WANG, S.Y., R. FENG, Y. LU, et al. 2005. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch). J. Agric. Food Chem. 53: 4187-4193.
28. KRIEHUBER, E., W. BAUER, A.S. CHARBONNIER, et al. 2005. Balance between NF-kappaB and JNK/AP-1 activity controls dendritic cell life and death. Blood 106: 175-183.
29. SHAO, R., E. RUNG, B. WEIJDEGARD & H. BILLIG. 2006. Induction of apoptosis increases SUMO-1 protein expression and conjugation in mouse periovulatory granulosa cells in vitro. Mol. Reprod. Dev. 73: 50-60.
30. LEE, Y.S., M.S. JANG, J.S. LEE, et al. 2005. SUMO-1 represses apoptosis signal-regulating kinase 1 activation through physical interaction and not through covalent modification. EMBO Rep. 6: 949-955.
31. ZHU, C.H., Y. HUANG, L.W. OBERLEY & F.E. DOMANN. 2001. A family of AP-2 proteins down-regulate manganese superoxide dismutase expression. J. Biol. Chem. 276: 14407-14413.
32. NEVE, R.L. 2003. A new wrestler in the battle between alpha- and beta-secretases for cleavage of APP. Trends Neurosci. 26: 461-463.
33. LI, Y., H. WANG, S. WANG, et al. 2003. Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc. Natl. Acad. Sci. USA 100: 259-264.
34. STEFFAN, J.S., N. AGRAWAL, J. PALLOS, et al. 2004. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304: 100-104.
35. UEDA, H., J. GOTO, H. HASHIDA, et al. 2002. Enhanced SUMOylation in polyglutamine diseases. Biochem. Biophys. Res. Commun. 293: 307-313.